相关实验视频
Updated: Jul 6, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
890
血小板数量减少对术后复发慢性腹腔内血瘤的影响
Kenji Yagi1, Maoki Matsubara1, Eiichiro Kanda2
1Department of Neurosurgery, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Frontiers in neurology
|January 5, 2024
概括
低血小板计数 (PC) 与手术后慢性腹腔内血瘤 (CSDH) 复发有关. 患有CSDH和PC降低的患者需要密切监测,以防止重复发生.
科学领域:
- 神经外科 神经外科
- 血液学 血液学 血液学
背景情况:
- 慢性腹膜下血腫 (CSDH) 經常用孔手術治療.
- 对于CSDH的术后复发率在10-20%之间.
研究的目的:
- 调查手术前血小板计数 (PC) 与CSDH复发风险之间的关联.
- 确定PC作为CSDH复发的潜在预测因素.
主要方法:
- 对431名患者 (488个大脑半球) 的回顾性审查,他们接受了CSDH的洞手术.
- 定义的降低PC为<170 × 10^3/μL.
- 分析了术前PC和术后复发之间的相关性.
主要成果:
- 在8.5%的病例 (39/459个半球) 中,CSDH复发.
- 复发率随着PC降低而增加:PC降低的13.8%,正常PC的6.9% (p=0.03).
- 降低PC和富含乙氨基酸的血液是复发的独立风险因素 (aOR分别为2.15和2.51).
结论:
- 手术前血小板数量的减少与CSDH复发有显著的关联.
- 患有CSDH和低PC的患者需要保持警的术后随访.
更多相关视频
相关概念视频
Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Introduction to Hemostasis
7.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.9K
Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
Extrinsic and Intrinsic Pathways of Hemostasis
7.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702

